Showing 1 - 20 results of 42 for search '"Multiple Myeloma drug therapy"', query time: 1.16s Refine Results
2

Source: Højholt, K L, Gregersen, H, Szabo, A G, Klausen, T W, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Rahbek Gjerdrum, L M, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Iversen, K F, Teodorescu, E M, Kurt, E, Strandholdt, C, Andersen, M K & Vangsted, A J 2021, ' Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients ', Hematological Oncology, vol. 39, no. 4, pp. 521-528 . https://doi.org/10.1002/hon.2906

3
4

Source: International Journal of Nanomedicine
Journal of Nanomedicine, 13, 8105. Dove Medical Press Ltd.
International Journal of Nanomedicine, 13, 8105
International Journal of Nanomedicine, Vol Volume 13, Pp 8105-8118 (2018)

File Description: image/pdf; text/html

5

Contributors: Hematology laboratory, Hematology, CCA - Cancer biology and immunology, AII - Cancer immunology, Physiology, Clinical genetics

Source: Krejcik, J, Frerichs, K A, Nijhof, I S, van Kessel, B, van Velzen, J, Bloem, A C, Broekmans, M, Zweegman, S, van Meerloo, J, Musters, R J, Poddighe, P, Groen, R, Chiu, C, Plesner, T, Lokhorst, H M, Sasser, A K, Mutis, T & van de Donk, N W C J 2017, ' Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab ', Clinical Cancer Research, vol. 23, no. 24, pp. 7498-7511 . https://doi.org/10.1158/1078-0432.CCR-17-2027
Clinical Cancer Research, 23(24), 7498-7511. American Association for Cancer Research Inc.

6

Contributors: Department of Hematology

Source: Annals of Hematology, 98(9), 2139-2150
Annals of hematology
Annals of Hematology
Annals of hematology, 98 (9

File Description: application/pdf; 1 full-text file(s): application/pdf

7

Source: Facon, T, Kumar, S, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O’Dwyer, M, Perrot, A, Venner, C P, Weisel, K, Mace, J R, Raje, N, Attal, M, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Ahmadi, T, Chiu, C, Wang, J, Rampelbergh, R V, Uhlar, C M, Kobos, R, Qi, M, Usmani, S Z, MAIA Trial Investigators & Abildgaard, N 2019, ' Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma ', New England Journal of Medicine, vol. 380, no. 22, pp. 2104-2115 . https://doi.org/10.1056/NEJMoa1817249

File Description: application/pdf

8

Source: Nielsen, L K, Abildgaard, N, Jarden, M & Klausen, T W 2019, ' Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma ', British Journal of Haematology, vol. 185, no. 1, pp. 11-24 . https://doi.org/10.1111/bjh.15759
Kongsgaard Nielsen, L, Abildgaard, N, Jarden, M E & Klausen, T W 2019, ' Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma ', British Journal of Haematology, vol. 185, no. 1, pp. 11-24 . https://doi.org/10.1111/bjh.15759

File Description: application/pdf

9

Authors: Dimopoulos, Meletios A, Gay, Francesca, Schjesvold, Fredrik, Beksac, Meral, Hajek, Roman, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Min, Chang Ki, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Mateos, Maria-Victoria, Spencer, Andrew, Iida, Shinsuke, Morgan, Gareth, Suryanarayan, Kaveri, Teng, Zhaoyang, Skacel, Tomas, Palumbo, Antonio, Dash, Ajeeta B, Gupta, Neeraj, Labotka, Richard, Rajkumar, S Vincent, Bar, Daniel, Basso, Alfredo, Fantl, Dorotea, He, Simon, Horvath, Neomi, Lee, Cindy, Rowlings, Phillip, Taylor, Kerry, Cochrane, Tara, Kwok, Fiona, Ramanathan, Sundreswran, Agis, Hermine, Zojer, Niklas, Kentos, Alain, Offner, Fritz, Van Droogenbroeck, Jan, Wu, Ka Lung, Maiolino, Angelo, Martinez, Gracia, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Pour, Ludek, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Helleberg, Carsten, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Delarue, Richard, Blau, Igor, Schieferdecker, Aneta, Teleanu, Veronica, Munder, Markus, Röllig, Christoph, Salwender, Han-Juergen, Fuhrmann, Stephan, Weisel, Katja, Duerig, Jan, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Schmidt, Christian, Scheid, Christof, Mayer, Karin, Hoffmann, Martin, Sosada, Markus, Dimopoulos, Athanasios, Delimpasi, Sosana, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Nagy, Zsolt, Illés, Árpád, Egyed, Miklós, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Shvetz, Olga, Trestman, Svetlana, Ruchlemer, Rosa, Nagler, Arnon, Tadmor, Tamar, Rouvio, Ory, Preis, Meir, Cavo, Michele, De Rosa, Luca, Musto, Pellegrino, Cafro, Anna, Tosi, Patrizia, Offidani, Massimo, Corso, Alessandro, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Suzuki, Kenshi, Nakaseko, Chiaki, Ishikawa, Takayuki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Takezako, Naoki, Hagiwara, Shotaro, Eom, Hyeon Seok, Jo, Deog-Yeon, Kim, Jin Seok, Lee, Jae Hoon, Yoon, Sung Soo, Yoon, Dok Hyun, Kim, Kihyun, Levin, Mark-David, Vellenga, Edo, Minnema, Monique, Waage, Anders, Haukås, Einar, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Marques, Herlander, Bergantim, Rui, Campilho, Fernando, Chng, Wee Joo, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, González Montes, Yolanda, Martin Sanchez, Jesus, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, Rosinol, Laura, San Miguel, Jesús, Pérez de Oteyza, Jaime, Encinas, Cristina, Alegre-Amor, Adrian, López-Guía, Ana, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Hveding Blimark, Cecile, Mueller, Rouven, Chen, Chih-Cheng, Liu, Ta-Chih, Huang, Shang-Yi, Wang, Po-Nan, Na Nakorn, Thanyaphong, Prayongratana, Kannadit, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Chaidos, Aristeidis, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Wechalekar, Ashutosh, Garg, Mamta, Ramasamy, Karthik, Cook, Gordon, Chantry, Andrew, Jenner, Matthew, Buadi, Francis, Berryman, Robert, Janakiram, Murali

Contributors: Takeda Pharmaceutical Company, CCA - Treatment and quality of life, CCA - Imaging and biomarkers, CCA - Cancer biology and immunology, Hematology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL)

Source: Lancet, 393(10168), 253. Elsevier Limited
The Lancet, 393(10168), 253-264. Elsevier Limited
Dimopoulos, M A, Gay, F, Schjesvold, F, Beksac, M, Hajek, R, Weisel, K C, Goldschmidt, H, Maisnar, V, Moreau, P, Min, C K, Pluta, A, Chng, W-J, Kaiser, M, Zweegman, S, Mateos, M-V, Spencer, A, Iida, S, Morgan, G, Suryanarayan, K, Teng, Z, Skacel, T, Palumbo, A, Dash, A B, Gupta, N, Labotka, R, Rajkumar, S V, Abildgaard, N & TOURMALINE-MM3 study group 2019, ' Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial ', Lancet, vol. 393, no. 10168, pp. 253-264 . https://doi.org/10.1016/S0140-6736(18)33003-4
LANCET, 393(10168), 253-264. ELSEVIER SCIENCE INC

File Description: image/pdf; application/pdf

10

Contributors: Hematology, CCA - Clinical Therapy Development

Source: Usmani, S Z, Weiss, B M, Plesner, T, Bahlis, N J, Belch, A, Lonial, S, Lokhorst, H M, Voorhees, P M, Richardson, P G, Chari, A, Sasser, A K, Axel, A, Feng, H, Uhlar, C M, Wang, J, Khan, I, Ahmadi, T & Nahi, H 2016, ' Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma ', Blood, vol. 128, no. 1, pp. 37-44 . https://doi.org/10.1182/blood-2016-03-705210
Blood, 128(1), 37-44. American Society of Hematology

11

Contributors: Hematology, CCA - Clinical Therapy Development

Source: Drugs, 76(8), 853-867. Adis International Ltd
Moreau, P, van de Donk, N W C J, San Miguel, J, Lokhorst, H, Nahi, H, Ben-Yehuda, D, Cavo, M, Cook, G, Delforge, M, Einsele, H, Zweegman, S, Ludwig, H, Driessen, C, Palumbo, A, Facon, T, Plesner, T, Dimopoulos, M, Sondergeld, P, Sonneveld, P & Mateos, M-V 2016, ' Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma ', Drugs, vol. 76, no. 8, pp. 853-867 . https://doi.org/10.1007/s40265-016-0573-4

File Description: STAMPA

12

Contributors: Université Cadi Ayyad [Marrakech] (UCA), Chimie des Substances Naturelles (ICMRCSN), Institut de Chimie Moléculaire de Reims - UMR 7312 (ICMR), Centre National de la Recherche Scientifique (CNRS)-Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-SFR Condorcet, Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS), University of Geneva [Switzerland]

Source: Pharmaceutical Biology
Pharmaceutical Biology, Taylor & Francis, 2018, 56 (1), pp.505-510. ⟨10.1080/13880209.2018.1499781⟩
Pharmaceutical Biology, Vol 56, Iss 1, Pp 505-510 (2018)
Pharmaceutical Biology, Vol. 56, No 1 (2018) pp. 505-510

13

Contributors: Hematology, CCA - Clinical Therapy Development

Source: Plesner, T, Arkenau, H-T, Gimsing, P, Krejcik, J, Lemech, C, Minnema, M C, Lassen, U, Laubach, J P, Palumbo, A, Lisby, S, Basse, L, Wang, J, Sasser, A K, Guckert, M E, de Boer, C, Khokhar, N Z, Yeh, H, Clemens, P L, Ahmadi, T, Lokhorst, H M & Richardson, P G 2016, ' Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma ', Blood, vol. 128, no. 14, pp. 1821-1828 . https://doi.org/10.1182/blood-2016-07-726729
Blood, 128(14), 1821-1828. American Society of Hematology
Blood, 128(14), 1821. American Society of Hematology

File Description: image/pdf

14

Source: Dimopoulos, M A, Oriol, A, Nahi, H, San-Miguel, J, Bahlis, N J, Usmani, S Z, Rabin, N, Orlowski, R Z, Komarnicki, M, Suzuki, K, Plesner, T, Yoon, S-S, Ben Yehuda, D, Richardson, P G, Goldschmidt, H, Reece, D, Lisby, S, Khokhar, N Z, O'Rourke, L, Chiu, C, Qin, X, Guckert, M, Ahmadi, T, Moreau, P & POLLUX Investigators 2016, ' Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma ', The New England Journal of Medicine, vol. 375, no. 14, pp. 1319-1331 . https://doi.org/10.1056/NEJMoa1607751

File Description: application/pdf

15

Contributors: Hematology, Hematology laboratory, CCA - Innovative therapy

Source: New England Journal of Medicine, 373(13), 1207-1219. Massachussetts Medical Society
Lokhorst, H M, Plesner, T, Laubach, J P, Nahi, H, Gimsing, P, Hansson, M, Minnema, M C, Lassen, U, Krejcik, J, Palumbo, A, van de Donk, N, Ahmadi, T, Khan, I, Uhlar, C M, Wang, J, Sasser, A K, Losic, N, Lisby, S, Basse, L, Brun, N & Richardson, P G 2015, ' Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma ', The New England Journal of Medicine, vol. 373, no. 13, pp. 1207-1219 . https://doi.org/10.1056/NEJMoa1506348
New England Journal of Medicine, 373(13), 1207. Massachussetts Medical Society

File Description: image/pdf

16
17

Source: OncoTargets and therapy
OncoTargets and Therapy, Vol 2009, Iss default, Pp 105-113 (2009)
Oncotargets and Therapy, vol. 2, no. 9, pp. 105-113

File Description: text/html; application/pdf

18

Source: Søe, K, Delaissé, J-M, Jakobsen, E H, Hansen, C & Plesner, T 2014, ' Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer ', Acta Oncologica, vol. 53, no. 4, pp. 547-556 . https://doi.org/10.3109/0284186X.2013.844358

19
20

Source: Swiss Medical Weekly, vol. 140, pp. w13054
Schweizerische medizinische Wochenschrift, Vol. 140 (2010) P. w13054

File Description: application/pdf